DXB 4.35% 44.0¢ dimerix limited

Ann: Investor Presentation, page-100

  1. 1,689 Posts.
    lightbulb Created with Sketch. 114
    I know from experience that Rituximab was recommended by one of the Renal doctors. But also know it is not for everyone.

    It's good to get some opposing view to challenge the thesis. I don't know why everyone so sensitive about this.

    I see Rituximab as the cheaper and more affordable option before people look at the Dimerix offering.
 
watchlist Created with Sketch. Add DXB (ASX) to my watchlist
(20min delay)
Last
44.0¢
Change
-0.020(4.35%)
Mkt cap ! $247.7M
Open High Low Value Volume
45.0¢ 45.5¢ 44.0¢ $628.7K 1.398M

Buyers (Bids)

No. Vol. Price($)
13 132686 44.0¢
 

Sellers (Offers)

Price($) Vol. No.
44.5¢ 21213 4
View Market Depth
Last trade - 11.41am 30/07/2024 (20 minute delay) ?
DXB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.